Planta Med 2019; 85(01): 81-87
DOI: 10.1055/a-0725-8295
Natural Product Chemistry and Analytical Studies
Original Papers
Thieme. All rights reserved. (2020) Georg Thieme Verlag KG

Direct-Injection Electron Ionization-Mass Spectrometry Metabolomics Method for Analyzing Blueberry Leaf Metabolites That Inhibit Adult T-cell Leukemia Proliferation

Hisahiro Kai
1   Department of Pharmaceutical Health Sciences, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Nobeoka, Japan
,
Yoshihiro Uesawa
2   Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose, Japan
,
Hisato Kunitake
3   Department of Biochemistry and Applied Biosciences, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan
,
Kazuhiro Morishita
4   Division of Tumor and Cellular Biochemistry, Department of Medical Sciences, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
,
Yoshihito Okada
5   Department of Natural Medicine and Phytochemistry, Meiji Pharmaceutical University, Kiyose, Japan
,
Koji Matsuno
1   Department of Pharmaceutical Health Sciences, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Nobeoka, Japan
› Author Affiliations
Further Information

Publication History

received 16 April 2018
revised 18 August 2018

accepted 22 August 2018

Publication Date:
13 September 2018 (online)

Abstract

Metabolic profiling is often used to identify possible correlations between a compoundʼs metabolic profile and biological activity. Direct-injection electron ionization-mass spectrometry “fingerprinting” is useful for characterizing biological materials. We demonstrate the utility of direct-injection electron ionization-mass spectrometry for metabolic profiling using 100 different extracts of leaves from 20 blueberry cultivars collected at 5 time points from April to December 2008. A qualitative direct-injection electron ionization-mass spectrometry method was used to profile the major and/or minor constituents in the blueberry leaf extracts. Blueberry leaf extracts could be distinguished by principal component analysis based on the absolute intensity of characteristic fragment ions. Twenty cultivars were categorized into four species, and the most appropriate discriminative marker m/z value for identifying each cultivar was selected statistically. Correlated m/z values indicating the collection month were determined in the same analysis, and air temperature variance factors were extracted from score plots by principal component analysis. We previously reported that blueberry extracts inhibit the proliferation of adult T-cell leukemia cells. Leaves of Vaccinium virgatum collected in December of 2008 exhibited significantly greater inhibition of adult T-cell leukemia cell proliferation than other species. Highly bioactive cultivars or species were identified by direct-injection electron ionization-mass spectrometry metabolomics analysis of blueberry leaf extracts. The components extracted based on our direct-injection electron ionization-mass spectrometry analyses could be used to construct a model to predict anti-adult T-cell leukemia bioactivity. This is the first study to report a relationship between seasonal variation and bioactivity of natural products using a direct-injection electron ionization-mass spectrometry metabolomics method.

Supporting Information

 
  • References

  • 1 Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 2004; 22: 245-252
  • 2 Johanningsmeier SD, Harris GK, Klevorn CM. Metabolomic technologies for improving the quality of food: practice and promise. Annu Rev Food Sci Technol 2016; 7: 413-438
  • 3 Aretz I, Meierhofer D. Advantages and pitfalls of mass spectrometry based metabolome profiling in systems biology. Int J Mol Sci 2016; 17: 632
  • 4 Van Der Kooy F, Maltese F, Young HC, Hye KK, Verpoorte R. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting. Planta Med 2009; 75: 763-775
  • 5 Gad HA, El-Ahmady SH, Abou-Shoer MI, Al-Azizi MM. Application of chemometrics in authentication of herbal medicines: a review. Phytochem Anal 2013; 24: 1-24
  • 6 Ernst M, Silva DB, Silva RR, Vêncio RZ, Lopes NP. Mass spectrometry in plant metabolomics strategies: from analytical platforms to data acquisition and processing. Nat Prod Rep 2014; 31: 784-806
  • 7 Kai H, Kinoshita K, Harada H, Uesawa Y, Maeda A, Suzuki R, Okada Y, Takahashi K, Matsuno K. Establishment of a direct-injection electron ionization-mass spectrometry metabolomics method and its application to Lichen profiling. Anal Chem 2017; 89: 6408-6414
  • 8 Tureček F, Hanuš V. Retro-Diels-Alder reaction in mass spectrometry. Mass Spectrom Rev 1984; 3: 85-152
  • 9 Biemann K. Mass Spectrometry. New York: McGraw-Hill; 1962
  • 10 Cignarella A, Nastasi M, Cavalli E, Puglisi L. Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res 1996; 84: 311-322
  • 11 McIntyre KL, Harris CS, Saleem A, Beaulieu LP, Ta CA, Haddad PS, Arnason JT. Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium). Planta Med 2009; 75: 286-292
  • 12 Kunitake H, Tsuda H, Takagi R, Ohno Y, Kuroki Y, Yoshioka K, Kage T, Ito T, Komatsu H. Possibility of wild blueberry Shashanbo (Vaccinium bracteatum Thunb.) as a rootstock for cultivation of northern highbush blueberry in warm region. Hortic Res 2006; 5: 105-110
  • 13 Kai H, Fuse T, Kunitake H, Morishita K, Matsuno K. Comparison of cultivars and seasonal variation in blueberry (Vaccinium species) leaf extract on adult T-cell leukemia cell line growth suppression. Medicines (Basel) 2014; 1: 3-11
  • 14 Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M, Sano M, Ikeda S, Takatsuki K, Kozuru M, Araki K, Kawano F, Niimi M, Tobinai K, Hotta T, Shimoyama M. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375-382